Aldeyra Therapeutics (ALDX) Earnings Call Presentation

R E P R O X A L A P F O R T H E P O T E N T I A L T R E A T M E N T O F D R Y E Y E D I S E A S E Topline Data Release and NDA Resubmission Plan May 6, 2025 Nasdaq: ALDX © Aldeyra Therapeutics, Inc. 2025 Disclaimers and Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding Aldeyra's possible or assumed future ...